GRAM plus ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSI): RECENT TRENDS IN UNITED STATES HOSPITAL ADMISSIONS

被引：0
|
作者：
Khachatryan, A. [1 ]
Stephens, J. M. [1 ]
Johnson, K. E. [2 ]
Patel, D. A. [1 ]
Patel, A. [3 ]
Kaye, K. S. [4 ,5 ]
机构：
[1] Pharmerit Int, Bethesda, MD USA
[2] Durata Therapeut, Chicago, IL USA
[3] Univ Houston, Houston, TX USA
[4] Wayne State Univ, Detroit, MI USA
[5] Detroit Med Ctr, Detroit, MI USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1552
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN9
引用
收藏
页码：A266 / A266
页数：1
相关论文
共 50 条
  • [41] Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections
    Ferrandez, Olivia
    Urbina, Olatz
    Grau, Santiago
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 65 - 82
  • [42] The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)
    Soriano, Alex
    Rossolini, Gian Maria
    Pea, Federico
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (05) : 415 - 422
  • [43] Current and emerging drugs for acute bacterial skin and skin structure infections: an update
    Kollipara, Ramya
    Downing, Christopher
    Lee, Michael
    Guidry, Jacqueline
    Curtis, Stephen
    Tyring, Stephen
    EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (03) : 431 - 440
  • [44] Clinical outcomes of ceftobiprole in the treatment of acute bacterial skin and skin structure infections
    Lee, Guang-Mao
    Chao, Chien-Ming
    Lai, Chih-Cheng
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 24 : 303 - 305
  • [45] Evaluation of dalbavancin on length of stay in acute bacterial skin and skin structure infections
    Jones, Bruce M. M.
    Hersey, Roby
    Taylor, Colleen
    Bland, Christopher M. M.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2019, 2 (05): : 477 - 481
  • [46] Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Kaul, G.
    Kapoor, E.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2018, 54 (11) : 657 - 666
  • [47] USE OF DALBAVANCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN THE SPANISH HOSPITAL SETTING: A COMPARATIVE COST ANALYSIS
    Hernandez, I
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    Jimenez, A.
    VALUE IN HEALTH, 2022, 25 (12) : S188 - S188
  • [48] Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
    McCarthy, Matthew W.
    Keyloun, Katelyn R.
    Gillard, Patrick
    Choi, Justin J.
    Pickell, Nicholas
    Copp, Ronald
    Walsh, Thomas J.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (01) : 53 - 67
  • [49] ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI): PRACTICE GUIDELINES FOR MANAGEMENT AND CARE TRANSITIONS IN THE EMERGENCY DEPARTMENT AND HOSPITAL
    Pollack, Charles V., Jr.
    Amin, Alpesh
    Ford, William T.
    Finley, Richard
    Kaye, Keith S.
    Nguyen, Hien H.
    Rybak, Michael J.
    Talan, David
    JOURNAL OF EMERGENCY MEDICINE, 2015, 48 (04): : 508 - 519
  • [50] Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial
    Matthew W. McCarthy
    Katelyn R. Keyloun
    Patrick Gillard
    Justin J. Choi
    Nicholas Pickell
    Ronald Copp
    Thomas J. Walsh
    Infectious Diseases and Therapy, 2020, 9 : 53 - 67
12345